The mutated p53 gene (TP53) has been detected in approximately 50% of all human tumors, such as breast, brain, lung, or colorectal carcinomas, among others [80], which may deeply condition the prognosis and clinical outcomes of oncological patients. The gene discussed is TP53; the disease is colorectal carcinoma.